133 related articles for article (PubMed ID: 23844653)
1. Synthesis and identification of new flavonoids targeting liver X receptor β involved pathway as potential facilitators of Aβ clearance with reduced lipid accumulation.
Hu Y; Yang Y; Yu Y; Wen G; Shang N; Zhuang W; Lu D; Zhou B; Liang B; Yue X; Li F; Du J; Bu X
J Med Chem; 2013 Aug; 56(15):6033-53. PubMed ID: 23844653
[TBL] [Abstract][Full Text] [Related]
2. Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis.
Terwel D; Steffensen KR; Verghese PB; Kummer MP; Gustafsson JÅ; Holtzman DM; Heneka MT
J Neurosci; 2011 May; 31(19):7049-59. PubMed ID: 21562267
[TBL] [Abstract][Full Text] [Related]
3. ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.
Donkin JJ; Stukas S; Hirsch-Reinshagen V; Namjoshi D; Wilkinson A; May S; Chan J; Fan J; Collins J; Wellington CL
J Biol Chem; 2010 Oct; 285(44):34144-54. PubMed ID: 20739291
[TBL] [Abstract][Full Text] [Related]
4. Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice.
Skerrett R; Pellegrino MP; Casali BT; Taraboanta L; Landreth GE
J Biol Chem; 2015 Aug; 290(35):21591-602. PubMed ID: 26163517
[TBL] [Abstract][Full Text] [Related]
5. Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice.
Fitz NF; Cronican A; Pham T; Fogg A; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2010 May; 30(20):6862-72. PubMed ID: 20484628
[TBL] [Abstract][Full Text] [Related]
6. Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury.
Loane DJ; Washington PM; Vardanian L; Pocivavsek A; Hoe HS; Duff KE; Cernak I; Rebeck GW; Faden AI; Burns MP
J Neurotrauma; 2011 Feb; 28(2):225-36. PubMed ID: 21175399
[TBL] [Abstract][Full Text] [Related]
7. ApoE promotes the proteolytic degradation of Abeta.
Jiang Q; Lee CY; Mandrekar S; Wilkinson B; Cramer P; Zelcer N; Mann K; Lamb B; Willson TM; Collins JL; Richardson JC; Smith JD; Comery TA; Riddell D; Holtzman DM; Tontonoz P; Landreth GE
Neuron; 2008 Jun; 58(5):681-93. PubMed ID: 18549781
[TBL] [Abstract][Full Text] [Related]
8. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening.
Li N; Wang X; Zhang J; Liu C; Li Y; Feng T; Xu Y; Si S
Biochem Pharmacol; 2014 Dec; 92(3):438-47. PubMed ID: 25450668
[TBL] [Abstract][Full Text] [Related]
10. ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.
Di D; Wang Z; Liu Y; Luo G; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2012 Apr; 421(1):152-6. PubMed ID: 22516753
[TBL] [Abstract][Full Text] [Related]
11. The liver X receptor agonist GW3965 improves recovery from mild repetitive traumatic brain injury in mice partly through apolipoprotein E.
Namjoshi DR; Martin G; Donkin J; Wilkinson A; Stukas S; Fan J; Carr M; Tabarestani S; Wuerth K; Hancock RE; Wellington CL
PLoS One; 2013; 8(1):e53529. PubMed ID: 23349715
[TBL] [Abstract][Full Text] [Related]
12. Activation of liver X receptor decreases BACE1 expression and activity by reducing membrane cholesterol levels.
Cui W; Sun Y; Wang Z; Xu C; Xu L; Wang F; Chen Z; Peng Y; Li R
Neurochem Res; 2011 Oct; 36(10):1910-21. PubMed ID: 21630010
[TBL] [Abstract][Full Text] [Related]
13. The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease.
Riddell DR; Zhou H; Comery TA; Kouranova E; Lo CF; Warwick HK; Ring RH; Kirksey Y; Aschmies S; Xu J; Kubek K; Hirst WD; Gonzales C; Chen Y; Murphy E; Leonard S; Vasylyev D; Oganesian A; Martone RL; Pangalos MN; Reinhart PH; Jacobsen JS
Mol Cell Neurosci; 2007 Apr; 34(4):621-8. PubMed ID: 17336088
[TBL] [Abstract][Full Text] [Related]
14. ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.
Corona AW; Kodoma N; Casali BT; Landreth GE
J Neuroimmune Pharmacol; 2016 Mar; 11(1):61-72. PubMed ID: 26175148
[TBL] [Abstract][Full Text] [Related]
15. Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonist.
Fitz NF; Castranio EL; Carter AY; Kodali R; Lefterov I; Koldamova R
J Alzheimers Dis; 2014; 41(2):535-49. PubMed ID: 24643138
[TBL] [Abstract][Full Text] [Related]
16. Effect of liver X receptor agonist TO901317 on cognitive function in APP/PS1 double transgenic mice with Alzheimer
Luo Y; Tan X; Zhang X; Li Y; Huang J; Deng Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1324-1331. PubMed ID: 36411683
[TBL] [Abstract][Full Text] [Related]
17. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
[TBL] [Abstract][Full Text] [Related]
18. Role of Liver X Receptor in AD Pathophysiology.
Sandoval-Hernández AG; Buitrago L; Moreno H; Cardona-Gómez GP; Arboleda G
PLoS One; 2015; 10(12):e0145467. PubMed ID: 26720273
[TBL] [Abstract][Full Text] [Related]
19. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
[TBL] [Abstract][Full Text] [Related]
20. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
